Use of Testosterone‐Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series
Jacob Rong Bentsen, Torbjørn Lien Kjær, Magnus Roland Balleby, Jimmi Nielsen · 2026
Read Use of Testosterone‐Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series by Jacob Rong Bentsen, Torbjørn Lien Kjær, Magnus Roland Balleby, Jimmi Nielsen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13238502.txt.
Description
Jacob Rong Bentsen and team reported a nationwide case series in 2026 on testosterone-lowering drugs given to men with intellectual disabilities and problematic sexual behavior. Such drugs are used in severe cases, yet their use in this group was poorly tracked. A survey of specialist clinics found five male patients who had received the treatment.
Four of the five showed reduced harmful behavior while treated, and three relapsed after the drug stopped. Side effects included bone thinning, high blood pressure, depression, and suppressed sexual development. Checks and access differed between regions. The authors conclude the drugs can work in selected patients, but only with careful checks and ethical oversight. The very small numbers underline how rare this treatment remains.
Catalog record
| CREATOR | Jacob Rong Bentsen, Torbjørn Lien Kjær, Magnus Roland Balleby, Jimmi Nielsen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |